| 000 | 01293 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250512195918.0 | ||
| 264 | 0 | _c19830527 | |
| 008 | 198305s 0 0 eng d | ||
| 022 | _a0093-7754 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aUnverferth, D V | |
| 245 | 0 | 0 |
_aN-acetylcysteine prevents the doxorubicin-induced decrease of cyclic GMP. _h[electronic resource] |
| 260 |
_bSeminars in oncology _cMar 1983 |
||
| 300 |
_a49-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAcetylcysteine _xpharmacology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
| 650 | 0 | 4 |
_aCyclic GMP _xmetabolism |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aElectrocardiography |
| 650 | 0 | 4 |
_aGuanylate Cyclase _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardium _xmetabolism |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aFertel, R H | |
| 700 | 1 | _aBalcerzak, S P | |
| 700 | 1 | _aMagorien, R D | |
| 700 | 1 | _aO'Dorisio, M S | |
| 773 | 0 |
_tSeminars in oncology _gvol. 10 _gno. 1 Suppl 1 _gp. 49-52 |
|
| 999 |
_c6132527 _d6132527 |
||